ALPS Advisors’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-66,109
Closed -$377K 1087
2025
Q3
$377K Sell
66,109
-8,441
-11% -$43.2K ﹤0.01% 926
2025
Q2
$376K Sell
74,550
-28,278
-28% -$152K ﹤0.01% 823
2025
Q1
$666K Sell
102,828
-8,532
-8% -$75.9K ﹤0.01% 554
2024
Q4
$817K Buy
+111,360
New +$878K 0.01% 535
2024
Q2
Sell
-95,242
Closed -$965K 1005
2024
Q1
$965K Buy
95,242
+3,124
+3% +$31.8K 0.01% 493
2023
Q4
$927K Sell
92,118
-7,001
-7% -$64K 0.01% 500
2023
Q3
$929K Buy
99,119
+641
+0.7% +$9.14K 0.01% 482
2023
Q2
$2.42M Buy
98,478
+10,505
+12% +$264K 0.02% 276
2023
Q1
$2.05M Sell
87,973
-2,239
-2% -$57.3K 0.02% 284
2022
Q4
$2.28M Buy
90,212
+17,794
+25% +$436K 0.02% 277
2022
Q3
$1.4M Sell
72,418
-21,126
-23% -$537K 0.01% 372
2022
Q2
$2.38M Buy
93,544
+78,374
+517% +$1.83M 0.02% 284
2022
Q1
$390K Buy
+15,170
New +$450K ﹤0.01% 496
2021
Q4
Sell
-160,089
Closed -$6.97M 981
2021
Q3
$6.97M Sell
160,089
-10,690
-6% -$463K 0.07% 162
2021
Q2
$8.07M Sell
170,779
-35,637
-17% -$1.62M 0.07% 152
2021
Q1
$10.6M Sell
206,416
-23,236
-10% -$1.25M 0.1% 143
2020
Q4
$6.15M Buy
229,652
+67,623
+42% +$2.2M 0.07% 164
2020
Q3
$5.56M Buy
162,029
+1,202
+0.7% +$51.8K 0.08% 152
2020
Q2
$6.59M Buy
+160,827
New +$5.4M 0.09% 140

Other funds holding VIR